4.5 Article

25-hydroxyvitamin D levels are inversely related to metabolic syndrome risk profile in northern Chinese subjects without vitamin D supplementation

Journal

DIABETOLOGY & METABOLIC SYNDROME
Volume 14, Issue 1, Pages -

Publisher

BMC
DOI: 10.1186/s13098-022-00793-1

Keywords

25-hydroxyvitamin D [25(OH)D]; Metabolic syndrome (MetS); Metabolic indices; Cross-sectional study; Longitudinal study

Funding

  1. Beijing Natural Science Foundation [7182130, 7082079]
  2. National Natural Science Foundation of China [81370898, 30771026, 30540036]
  3. China Diabetes Young Scientific Talent Research Project [2020-N-01-10]
  4. National Key Technology Research and Development Program of China during the 11th Five-Year Plan from the Ministry of Science and Technology [2006BAI01A01]
  5. National Key Program of Clinical Science [WBYZ2011-873]
  6. PUMCH Foundation [pumch-2013-020]
  7. Innovation fund for postgraduate students of Peking Union Medical College [2019-1002-26]

Ask authors/readers for more resources

This study investigated the relationship between serum 25(OH)D levels and MetS risk in a cohort of middle-aged Chinese subjects. The results showed that MetS patients had lower 25(OH)D levels, which were inversely associated with metabolic dysfunctions. With 1-year diet and exercise counselling, the metabolic status of MetS patients significantly improved along with elevated 25(OH)D levels.
Background The comparatively low 25 hydroxyvitamin D [25(OH)D] levels have been reported in patients with metabolic syndrome (MetS). Herein we investigated the cross-sectional and longitudinal relationships between serum 25(OH)D levels and MetS risk profile in northern middle-aged Chinese subjects without vitamin D supplementation. Methods A cohort of 211 participants including 151 MetS patients and 60 controls at 20-69 years of age were enrolled from suburban Beijing, China. The recruited MetS patients were subjected to diet and exercise counselling for 1-year. All subjects at baseline and MetS patients after intervention underwent clinical evaluations. Results Serum 25(OH)D levels were significantly decreased in MetS patients. 25(OH)D levels were inversely related to MetS score, fasting blood glucose (FBG) and triglyceride-glucose index (TyG) after adjusting for cofounders (all P < 0.05). Participants in the lowest tertile of 25(OH)D levels had increased odds for MetS (P = 0.045), elevated FBG (P = 0.004) in all subjects, and one MetS score gain in MetS patients (P = 0.005). Longitudinally, the metabolic statuses as well as 25(OH)D levels of MetS patients were significantly improved (all P < 0.05), and the increase of 25(OH)D levels were inversely related to MetS scores, total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), FBG, and TyG, while positively related to high-density lipoprotein cholesterol (HDL-C) after adjusting for confounders. Conclusions 25(OH)D levels were significantly decreased in MetS patients, and it was negatively associated with metabolic dysfunctions at baseline and 1-year after. Metabolic aberrations of MetS patients were significantly ameliorated with 1-year follow-up counselling accompanying by notably elevated 25(OH)D levels.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available